Abstract
The molecular mechanisms of action of 5-amino-exo-3-azatricyclo[5.2.1.02,6]decane-4-one (P11), a compound possessing strong antiarrhythmic, nootropic, anti-inflammatory and analgesic activity, have been studied. Cardiac rhythm disturbances were modeled by administering the arrhythmogenic compound aconitin in a dose of 50 μg/kg to the animals from the control group. P-11 in a dose of 0.3 mg/kg was injected intravenously in the experimental group of animals 2 min before aconitin administration. P-11 target genes were identified using the Atlas™ Rat cDNA Expression macroarray (#7738-1, BD Biosciences, United States). Reproducible changes in the expression levels of 16 genes in the heart of rats treated with P-11 concommitantly to arrhythmia modeling in vivo were detected. The genes regulated by the substance coded for proteins of the extracellular matrix are (glypican 1, Gpc1; tissue inhibitor of metalloproteinase 2, 3, Timp2, Timp3), intracellular signaling proteins (rho GTPase activating protein 7, Dlc1; protein tyrosine phosphatase 4a1, Ptp4a1; phosphodiesterase 4D, PDE4D; PI3-kinase regulatory subunit alpha, PIK3R1; guanine nucleotide binding protein alpha 12, Gna12), proteins involved in glycolysis (phosphofructokinase 1, Pfk1), intercellular interactions (junction plakoglobin, Jup), and hemostasis (tissue plasminogen activator, Plat), membranebound pumps and transporters (solute carrier family 16, member 1, Slc16a1; ATPase, Na+/K+ transporting, Atp1a), and others (c-fos proto-oncogene, c-fos; telomerase protein component 1, tlp; Annexin 1, anxa1). Therefore, the data concerning the selective effect of P-11 on genes coding for proteins involved in arrhythmogenesis allow for considering this compound as a promising medication for pathogenetically oriented therapy of arrhythmias.
Similar content being viewed by others
Abbreviations
- WHO:
-
World Health Organisation
- ECG:
-
electrocardiogram
- ED50-50%:
-
efficient dose
References
Informative Bulletin No. 317, WHO, 2009.
Vaughan Williams, E.M., J. Clin. Pharmacol., 1984, vol. 24, pp. 129–147.
Kaverina, N.V., Berdyaev, S.Yu., Kishchuk, E.P., and Paskhina, O.E., Vedom. Farmakol. Komit., 1998, no. 2, pp. 11–19.
Ross, H.M., Kocovic, D.Z., and Kowey, P.R., Am. J. Geriatr. Cardiol., 2005, vol. 14, no. (2), pp. 62–67.
Garpinchenko, V.A., Yatsynich, E.A., Petrov, D.V., Karachurina, L.T., and Khisamutdinova, R.Yu., Baschenko, N.Zh., Dokichev, V.A., Tomilov, Yu.V., Khim.-Farm. Zh., 2005, vol. 39, pp. 9–11.
Petrov, D.V., Gorpinchenko, V.A., Shafikova, E.A., Zarudii, F.S., Baschenko, N.Zh., Khisamutdinova, R.Yu., Makara, N.S., Vakhitov, V.A., Vakhitova, Yu.V., Chzhan Veimu, Alimbekov, R.I., Dokichev, V.A., Tomilov, Yu.V., and Nefedov, O.M., RF Patent No. 2281938, Byull. Izobret., 2006, no. 23.
Marri, R., in Biokhimiya cheloveka (Human Biochemistry), Moscow: Mir, 1993.
Russell, D.C., Lawrie, J.S., Riemersma, R.A., and Oliver, M.F., Acta Med. Scand. Suppl., 1981, vol. 651, pp. 71–81.
Saffitz, J.E., Ann. N. Y. Acad. Sci., 2005, vol. 1047, pp. 336–344.
Remme, C.A. and Bezzina, C.R., Cell Cycle, 2010, vol. 9, pp. 1246–1252.
Bierkamp, C., Mclaughlin, K.J., Schwarz, H., Huber, O., and Kemler, R., Dev. Biol., 1996, vol. 180, pp. 780–785.
Kaplan, S.R., Gard, J.J., Protonotarios, N., Tsatsopoulou, A., Spiliopoulou, C., Anastasakis, A., Squarcioni, C.P., McKenna, W.J., Thiene, G., Basso, C., Brousse, N., Fontaine, G., and Saffitz, J.E., Heart Rhythm, 2004, vol. 1, pp. 3–11.
Herren, T., Gerber, P.A., and Duru, F., Clin. Res. Cardiol., 2009, vol. 98, pp. 141–158.
Houslay, M.D., Schafer, P., and Zhang, K.Y., Drug Discov. Today, 2005, vol. 10, pp. 1503–1519.
Xiang, Y., Naro, F., Zoudilova, M., Jin, S.L., Conti, M., and Kobilka, B., Proc. Natl. Acad. Sci. USA, 2005, vol. 102, pp. 909–914.
Osadchii, O.E., Cardiovasc. Drugs Ther., 2007, vol. 21, pp. 171–194.
Leevers, S.J., Vanhaesebroeck, B., and Waterfield, M.D., Curr. Opin. Cell Biol., 1999, vol. 11, pp. 219–225.
Cantley, L.C., Science, 2002, vol. 296, pp. 1655–1657.
Fruman, D.A., Meyers, R.E., and Cantley, L.C., Annu. Rev. Biochem., 1998, vol. 67, pp. 481–507.
Luo, J., McMullen, J.R., Sobkiw, C.L., Zhang, L., Dorfman, A.L., Sherwood, M.C., Logsdon, M.N., Horner, J.W., DePinho, R.A., Izumo, S., and Cantley, L.C., Mol. Cell Biol., 2005, vol. 25, pp. 9491–9502.
Caporali, A. and Emanueli, C., Physiol. Rev., 2009, vol. 89, pp. 279–308.
Emanueli, C., Salis, M.B., Pinna, A., Graiani, G., Manni, L., and Madeddu, P., Circulation, 2002, vol. 106, pp. 2257–2262.
Kawaguchi-Manabe, H., Ieda, M., Kimura, K., Manabe, T., Miyatake, S., Kanazawa, H., Kawakami, T., Ogawa, S., Suematsu, M., and Fukuda, K., Life Sci., 2007, vol. 81, pp. 385–392.
Bonen, A., Eur. J. Appl. Physiol., 2001, vol. 86, pp. 6–11.
Vandenberg, J.I., Metcalfe, J.C., and Grace, A.A., Circ. Res., 1993, vol. 72, pp. 993–1003.
Bonen, A., Tonouchi, M., Miskovic, D., Heddle, C., Heikkila, J.J., and Halestrap, A.P., Am. J. Physiol. Endocrinol. Metab., 2000, vol. 279, pp. 1131–1138.
Boldyrev, A.A., Soros. Obrazovat. Zh., 1998, no. 4, pp. 2–9.
Helms, J.B., Arnett, K.L., Gatto, C., and Milanick, M.A., Blood Cells Mol. Dis., 2004, vol. 32, pp. 394–400.
Kostin, S., Klein, G., Szalay, Z., Hein, S., Bauer, E.P., and Schaper, J., Cardiovasc. Res., 2002, vol. 54, pp. 361–379.
Nattel, S. and Maguy, A., Le Bouter S., Yeh Y.H., Physiol. Rev., 2007, vol. 87, pp. 425–456.
Espira, L. and Czubryt, M.P., Can. J. Physiol. Pharmacol., 2009, vol. 87, pp. 996–1008.
Spinale, F.G., Physiol. Rev., 2007, vol. 87, pp. 1285–1342.
Vanhoutte, D., Schellings, M., Pinto, Y., and Heymans, S., Cardiovasc. Res., 2006, vol. 69, pp. 604–613.
Fedak, P.W.M., Smookler, D.S., Kassiri, Z., Ohno, N., Leco, K.J., et al., Circulation, 2004, vol. 110, pp. 2401–2409.
English, J.L., Kassiri, Z., Koskivirta, I., Atkinson, S.J., Di Grappa, M., et al., J. Biol. Chem., 2006, vol. 281, pp. 10337–10346.
Creemers, E.E., Cleutjens J.P., Smits J.F., Daemen M.J., Circ. Res., 2001, vol. 89, pp. 201–210.
Filmus, J. and Selleck, S.B., J. Clin. Invest., 2001, vol. 108, pp. 497–501.
Asundi, V.K., Keister, B.F., Stahl, R.C., and Carey, D.J., Exp. Cell Res., 1997, vol. 230, pp. 145–153.
Kirn-Safran, C., Farach-Carson, M.C., and Carson, D.D., Cell Mol. Life Sci., 2009, vol. 66, pp. 3421–3434.
Song, H.H., Shi, W., and Filmus, J., J. Biol. Chem., 1997, vol. 272, pp. 7574–7577.
Filmus, J., Capurro, M., and Rast, J., Genome Biol., 2008, vol. 9, p. 224.
Sanguinetti, M.C. and Bennett, P.B., Circ. Res., 2003, vol. 93, pp. 491–499.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © Yu.V. Vakhitova, E.I. Antipina, R.S. Yamidanov, R.Yu. Khisamutdinova, F.S. Zarudii, N.Zh. Baschenko, V.A. Dokichev, Yu.V. Tomilov, O.M. Nefedov, 2011, published in Bioorganicheskaya Khimiya, 2011, Vol. 37, No. 6, pp. 821–829.
Rights and permissions
About this article
Cite this article
Vakhitova, Y.V., Antipina, E.I., Yamidanov, R.S. et al. Genes targets identification of 5-amino-exo-3-azatricyclo[5.2.1.02,6]decane-4-one in an in vivo model of arrhythmia. Russ J Bioorg Chem 37, 744–751 (2011). https://doi.org/10.1134/S1068162011060148
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162011060148